STRS Ohio’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530K | Buy |
28,300
+6,700
| +31% | +$125K | ﹤0.01% | 1243 |
|
|
2025
Q1 | $389K | Sell |
21,600
-3,000
| -12% | -$54K | ﹤0.01% | 1310 |
|
|
2024
Q4 | $414K | Hold |
24,600
| – | – | ﹤0.01% | 1272 |
|
|
2024
Q3 | $398K | Buy |
24,600
+6,900
| +39% | +$112K | ﹤0.01% | 1350 |
|
|
2024
Q2 | $145K | Hold |
17,700
| – | – | ﹤0.01% | 1632 |
|
|
2024
Q1 | $261K | Hold |
17,700
| – | – | ﹤0.01% | 1483 |
|
|
2023
Q4 | $256K | Hold |
17,700
| – | – | ﹤0.01% | 1498 |
|
|
2023
Q3 | $191K | Hold |
17,700
| – | – | ﹤0.01% | 1574 |
|
|
2023
Q2 | $228K | Buy |
17,700
+1,380
| +8% | +$17.8K | ﹤0.01% | 1563 |
|
|
2023
Q1 | $215K | Hold |
16,320
| – | – | ﹤0.01% | 1583 |
|
|
2022
Q4 | $244K | Hold |
16,320
| – | – | ﹤0.01% | 1540 |
|
|
2022
Q3 | $192K | Hold |
16,320
| – | – | ﹤0.01% | 1614 |
|
|
2022
Q2 | $184K | Buy |
16,320
+920
| +6% | +$10.4K | ﹤0.01% | 1632 |
|
|
2022
Q1 | $460K | Hold |
15,400
| – | – | ﹤0.01% | 1471 |
|
|
2021
Q4 | $408K | Hold |
15,400
| – | – | ﹤0.01% | 1538 |
|
|
2021
Q3 | $559K | Buy |
+15,400
| New | +$559K | ﹤0.01% | 1465 |
|
|
2016
Q4 | – | Sell |
-17,570
| Closed | -$644K | – | 2018 |
|
|
2016
Q3 | $644K | Sell |
17,570
-3,560
| -17% | -$130K | ﹤0.01% | 1137 |
|
|
2016
Q2 | $471K | Buy |
21,130
+1,630
| +8% | +$36.3K | ﹤0.01% | 1320 |
|
|
2016
Q1 | $405K | Hold |
19,500
| – | – | ﹤0.01% | 1343 |
|
|
2015
Q4 | $590K | Buy |
19,500
+5,770
| +42% | +$175K | ﹤0.01% | 1207 |
|
|
2015
Q3 | $339K | Hold |
13,730
| – | – | ﹤0.01% | 1406 |
|
|
2015
Q2 | $440K | Buy |
+13,730
| New | +$440K | ﹤0.01% | 1364 |
|